Medigen Vaccine Biologics Corporation (TPEX:6547)

Medigen Vaccine Biologics Statistics

Total Valuation

TPEX:6547 has a market cap or net worth of TWD 16.31 billion. The enterprise value is 14.82 billion.

Market Cap	16.31B
Enterprise Value	14.82B

Important Dates

The next estimated earnings date is Friday, May 15, 2026.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:6547 has 328.75 million shares outstanding. The number of shares has decreased by -0.33% in one year.

Current Share Class	328.75M
Shares Outstanding	328.75M
Shares Change (YoY)	-0.33%
Shares Change (QoQ)	-1.43%
Owned by Insiders (%)	0.28%
Owned by Institutions (%)	1.99%
Float	253.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	26.59
PB Ratio	4.69
P/TBV Ratio	4.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-52.60
EV / Sales	24.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-148.59

Financial Position

The company has a current ratio of 12.77, with a Debt / Equity ratio of 0.08.

Current Ratio	12.77
Quick Ratio	10.35
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-2.84
Interest Coverage	-30.19

Financial Efficiency

Return on equity (ROE) is -7.69% and return on invested capital (ROIC) is -4.18%.

Return on Equity (ROE)	-7.69%
Return on Assets (ROA)	-4.00%
Return on Invested Capital (ROIC)	-4.18%
Return on Capital Employed (ROCE)	-7.09%
Weighted Average Cost of Capital (WACC)	8.50%
Revenue Per Employee	5.95M
Profits Per Employee	-2.74M
Employee Count	103
Asset Turnover	0.15
Inventory Turnover	0.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.99% in the last 52 weeks. The beta is 0.79, so TPEX:6547's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	-8.99%
50-Day Moving Average	37.45
200-Day Moving Average	39.62
Relative Strength Index (RSI)	82.94
Average Volume (20 Days)	1,454,567

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6547 had revenue of TWD 613.17 million and -281.71 million in losses. Loss per share was -0.86.

Revenue	613.17M
Gross Profit	364.67M
Operating Income	-265.69M
Pretax Income	-281.71M
Net Income	-281.71M
EBITDA	-123.90M
EBIT	-265.69M
Loss Per Share	-0.86

Balance Sheet

The company has 1.77 billion in cash and 283.44 million in debt, with a net cash position of 1.49 billion or 4.53 per share.

Cash & Cash Equivalents	1.77B
Total Debt	283.44M
Net Cash	1.49B
Net Cash Per Share	4.53
Equity (Book Value)	3.48B
Book Value Per Share	10.74
Working Capital	2.18B

Cash Flow

In the last 12 months, operating cash flow was -49.09 million and capital expenditures -50.64 million, giving a free cash flow of -99.72 million.

Operating Cash Flow	-49.09M
Capital Expenditures	-50.64M
Depreciation & Amortization	141.79M
Net Borrowing	-39.19M
Free Cash Flow	-99.72M
FCF Per Share	-0.30

Margins

Gross margin is 59.47%, with operating and profit margins of -43.33% and -45.94%.

Gross Margin	59.47%
Operating Margin	-43.33%
Pretax Margin	-45.94%
Profit Margin	-45.94%
EBITDA Margin	-20.21%
EBIT Margin	-43.33%
FCF Margin	n/a

Dividends & Yields

TPEX:6547 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.33%
Shareholder Yield	0.33%
Earnings Yield	-1.73%
FCF Yield	-0.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 3, 2022. It was a forward split with a ratio of 1.48280574.

Last Split Date	Aug 3, 2022
Split Type	Forward
Split Ratio	1.48280574

Scores

TPEX:6547 has an Altman Z-Score of 19.39 and a Piotroski F-Score of 3.

Altman Z-Score	19.39
Piotroski F-Score	3